Pain Management Drugs Companies: Abbott Laboratories, Eli Lilly, Endo International

The global pain management drugs market reached US$ 74 Billion in 2020. Pain is a distressing feeling which can be caused due to various health issues such as osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis and cancer. Pain mechanism is an intricate process, and there are several pain management drugs that provide relief by acting through various physiological functions. These medications are specific drugs that perform pharmacological actions on pain receptors and work against the discomfort-causing symptoms.

Market Breakup by Drug Class:

  • NSAIDs
  • Anesthetics
  • Anticonvulsants
  • Antimigraine Agents
  • Antidepressants
  • Opioids
  • Others

Request a Copy of Sample Report: https://www.imarcgroup.com/pain-management-drugs-market/requestsample

High prevalence of chronic pain diseases and increasing geriatric population are among the key factors driving the global pain management drugs market. In 2018, around 991 Million people across the globe were more than 60 years old. By 2024, we expect these figures to reach 1.18 Billion. With the prevalence of chronic pain being significantly higher in older adults, this represents a key factor driving the demand of pain management drugs. Additionally, the increasing number of hospitalization cases, a huge demand-supply gap for effective neuropathic pain management drugs, and application of innovative and advance therapies, are also catalyzing the growth of the market.

Top Companies in Pain Management Drugs Industry:

  • Abbott Laboratories
  • Pfizer
  • Eli Lilly & Company
  • Endo International plc
  • Hoffmann-La Roche AG
  • Bausch Health Companies
  • Merck
  • Allergen
  • Novartis International AG
  • Johnson & Johnson
  • GlaxoSmithKline Plc
  • Purdue Pharma L.P.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Also Read IMARC Group Reports:

https://www.imarcgroup.com/fluid-milk-market

https://www.imarcgroup.com/flavoured-milk-market-india

https://www.imarcgroup.com/butter-milk-market-india

https://www.imarcgroup.com/lassi-market-india

https://www.imarcgroup.com/flavoured-frozen-yoghurt-market-india

https://www.imarcgroup.com/curd-market-india

https://www.imarcgroup.com/cheese-market-in-india

https://www.imarcgroup.com/UK-diabetes-market

https://www.imarcgroup.com/canada-generic-drug-market

Elena Anderson

9+ years in chemical & material has made Elena more or less an expert in everything related to medicines, drugs, chemicals and related sectors – at least from the PR front. Through his insider access to the sector, he has gained valuable insight into the entire manufacturing process of chemical and material.
Back to top button